EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo-Reference-Cited by-同舟云学术

EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo

Published:2014-02-06 Issue:7 Volume:110 Page:1767-1777
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Wei J-H,Cao J-Z,Zhang D,Liao B,Zhong W-M,Lu J,Zhao H-W,Zhang J-X,Tong Z-T,Fan S,Liang C-Z,Liao Y-B,Pang J,Wu R-H,Fang Y,Chen Z-H,Li B,Xie D,Chen W,Luo J-H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201452.pdf

Reference30 articles.

1. Chen W, Luo JH, Hua WF, Zhou FJ, Lin MC, Kung HF, Zeng YX, Guan XY, Xie D (2009) Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy. Cancer Epidemiol Biomarkers Prev 18: 400–408.

2. Eder IE, Stenzl A, Hobisch A, Cronauer MV, Bartsch G, Klocker H (1996) Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma. J Urol 156: 953–957.

3. Eder IE, Stenzl A, Hobisch A, Cronauer MV, Bartsch G, Klocker H (1997) Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas. Br J Cancer 75: 1753–1760.

4. Eissa S, Salem AM, Zohny SF, Hegazy MG (2007) The diagnostic efficacy of urinary TGF-beta1 and VEGF in bladder cancer: comparison with voided urine cytology. Cancer Biomark 3: 275–285.

5. Guan XY, Fung JMW, Ma NF, Lau SH, Tai LS, Xie D, Zhang Y, Hu L, Wu QL, Fang Y, Sham JST (2004) Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res 64: 4197–4200.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of EIF5A2 in solid tumors: A meta-analysis and bioinformatics analysis;Open Medicine;2024-01-01

2. Codelivery of curcumin and siRNA as anticancer therapeutics;Curcumin-Based Nanomedicines as Cancer Therapeutics;2024

3. The Role and Therapeutic Potential of the TFAP2C-EIF5A Signaling Pathway in Bladder Cancer Development;2023-10-18

4. MicroRNA‐577/EIF5A2 axis suppressed the proliferation of DDP‐resistant nasopharyngeal carcinoma cells by blocking TGF‐β signaling pathway;Chemical Biology & Drug Design;2023-07-27

5. High levels of hypusinated eIF5A in leiomyoma and leiomyosarcoma pathologies: a possible novel therapeutic target;Reproductive BioMedicine Online;2023-07